Atlas Trials

Safety and Efficacy of Anricfen for Postoperative Analgesia and Rehabilitation Promotion After Pancreaticoduodenectomy.Intervention Measures: For Normal Adults, Administer Ariceptin Injection Intravenously Post-operation at a Dose of 1 μg/Kgevery 8 Hours for Three Consecutive Days After Surgery.

Clinical trial NCT07514637 · RECRUITING

Trial details

NCT number
NCT07514637
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Patients Who Undergo Pancreaticoduodenectomy
Start date
2025-11-25
Primary completion
2026-03-31
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.